Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
759.00
6.1 (0.81%)
BSENSE

Dec 05

BSE+NSE Vol: 50.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
13.37
13.37
13.37
13.37
12.34
12.34
Share Warrants & Outstandings
Total Reserve
547.58
474.18
446.97
427.08
374.19
311.03
Shareholder's Funds
560.95
487.55
460.34
440.45
400.28
323.37
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
38.68
38.68
38.68
46.83
72.05
Secured Loans
0.00
0.00
0.00
0.00
0.09
24.19
Unsecured Loans
0.00
38.68
38.68
38.68
46.74
47.87
Deferred Tax Assets / Liabilities
15.58
10.92
10.65
-0.68
3.63
16.85
Other Long Term Liabilities
0
0
0
0
0.28
0.29
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.90
10.26
8.85
7.95
7.38
6.63
Total Non-Current Liabilities
18.48
59.86
58.17
45.95
58.12
95.82
Current Liabilities
Trade Payables
91.86
53.18
50.84
50.17
71.36
36.70
Other Current Liabilities
36.65
22.53
27.23
37.66
20.92
101.70
Short Term Borrowings
1.69
2.65
3.61
4.17
4.49
85.58
Short Term Provisions
6.08
1.05
0.89
0.75
0.68
0.61
Total Current Liabilities
136.29
79.42
82.57
92.74
97.44
224.58
Total Liabilities
715.72
626.82
601.08
579.14
555.85
643.77
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
633.87
614.93
603.75
612.50
616.32
623.96
Less: Accumulated Depreciation
404.45
396.40
387.78
371.57
354.63
334.59
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
229.42
218.53
215.96
240.94
261.68
289.37
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
26.39
21.08
26.10
25.23
25.11
24.63
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.02
0.02
0.00
0.00
0.00
0.00
Long Term Loans & Advances
4.97
23.16
33.95
33.36
33.74
35.77
Other Non Current Assets
3.21
4.50
2.23
1.57
1.29
0.00
Total Non-Current Assets
264.00
267.30
278.25
301.10
321.82
349.77
Current Assets Loans & Advances
Current Investments
84.09
19.09
20.13
0.00
0.00
0.00
Inventories
100.49
121.69
119.94
125.64
119.99
141.12
Sundry Debtors
112.22
80.50
76.66
38.60
32.04
30.69
Cash and Bank
80.10
68.09
54.45
50.40
31.42
2.12
Other Current Assets
12.59
31.30
31.53
33.52
34.42
84.26
Short Term Loans and Advances
62.22
38.85
20.12
29.88
16.16
35.80
Total Current Assets
451.72
359.52
322.83
278.04
234.03
294.00
Net Current Assets (Including Current Investments)
315.43
280.11
240.26
185.30
136.59
69.43
Total Current Assets Excluding Current Investments
367.63
340.44
302.70
278.04
234.03
294.00
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
715.72
626.82
601.08
579.14
555.85
643.77
Contingent Liabilities
38.20
37.39
39.60
10.63
0.16
0.16
Total Debt
1.69
41.33
42.29
42.84
51.32
157.63
Book Value per share (adjusted)
419.65
364.74
344.38
329.5
313.18
262.01
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -95.91% vs -2.27% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 6.76% vs -1.01% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 25.65% vs 11.37% in Mar 2024

Compare Balance Sheet Results of Venus Remedies
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.37
0
13.37
0.00%
Share Warrants & Outstandings
Total Reserve
547.58
0
547.58
0.00%
Shareholder's Funds
560.95
0
560.95
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
0.00
0
0.00
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
15.58
0
15.58
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
2.90
0
2.90
0.00%
Total Non-Current Liabilities
18.48
0
18.48
0.00%
Current Liabilities
Trade Payables
91.86
0
91.86
0.00%
Other Current Liabilities
36.65
0
36.65
0.00%
Short Term Borrowings
1.69
0
1.69
0.00%
Short Term Provisions
6.08
0
6.08
0.00%
Total Current Liabilities
136.29
0
136.29
0.00%
Total Liabilities
715.72
0
715.72
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
633.87
0
633.87
0.00%
Less: Accumulated Depreciation
404.45
0
404.45
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
229.42
0
229.42
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
26.39
0
26.39
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.02
0
0.02
0.00%
Long Term Loans & Advances
4.97
0
4.97
0.00%
Other Non Current Assets
3.21
0
3.21
0.00%
Total Non-Current Assets
264.00
0
264.00
0.00%
Current Assets Loans & Advances
Current Investments
84.09
0
84.09
0.00%
Inventories
100.49
0
100.49
0.00%
Sundry Debtors
112.22
0
112.22
0.00%
Cash and Bank
80.10
0
80.10
0.00%
Other Current Assets
12.59
0
12.59
0.00%
Short Term Loans and Advances
62.22
0
62.22
0.00%
Total Current Assets
451.72
0
451.72
0.00%
Net Current Assets (Including Current Investments)
315.43
0
315.43
0.00%
Total Current Assets Excluding Current Investments
367.63
0
367.63
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
715.72
0
715.72
0.00%
Contingent Liabilities
38.20
0
38.20
0.00%
Total Debt
1.69
0
1.69
0.00%
Book Value per share (adjusted)
419.65
0
419.65
0.00%
Annual - Borrowings
Borrowings 1.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -95.91% vs -2.27% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 255.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.76% vs -1.01% in Mar 2024

Annual - Investments
Investments 0.02 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 451.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.65% vs 11.37% in Mar 2024